FDA inspection
Amphastar France Pharmaceuticals: FDA inspection ending Nov 25, 2022
FDA inspection 1206214 · Voluntary Action Indicated (VAI) · Eragny Sur Epte
Key facts
| Inspection ID | 1206214 |
|---|---|
| Firm | Amphastar France Pharmaceuticals |
| FEI number | 3003672088 |
| Address | Usine Saint Charles |
| City | Eragny Sur Epte |
| Country | France |
| Fiscal year | 2023 |
| Inspection end date | Nov 25, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data